Technology to transform neuromuscular disease treatment
Biogen’s Toby Ferguson explains why it is a promising time for the development of therapies for neuromuscular diseases, including ALS.
Source: europeanpharmaceuticalreview.com
Stay updated with breaking news from Phd Toby. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen’s Toby Ferguson explains why it is a promising time for the development of therapies for neuromuscular diseases, including ALS.